Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Nigeria
Nigeria: Diphtheria tetanus toxoid and pertussis third-dose (DTP3) was 62.0% in 2025. ▲ Rising
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Nigeria, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Nigeria recorded 62.0% for diphtheria tetanus toxoid and pertussis third-dose (dtp3) in 2025.
That represents a change of down 1.6% on the previous year and up 47.6% over ten years.
Over the whole period, diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Nigeria peaked at 66.0% in 2019 and was at its lowest, 25.0%, in 2002.
That places Nigeria 181st out of 194 countries with data for 2025, putting it in the bottom quarter.
The long-run direction has been consistently rising across the 26 years of available data.
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Nigeria, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 29.0% | — |
| 2001 | 27.0% | -6.9% |
| 2002 | 25.0% | -7.4% |
| 2003 | 29.0% | +16.0% |
| 2004 | 33.0% | +13.8% |
| 2005 | 36.0% | +9.1% |
| 2006 | 40.0% | +11.1% |
| 2007 | 42.0% | +5.0% |
| 2008 | 53.0% | +26.2% |
| 2009 | 63.0% | +18.9% |
| 2010 | 56.0% | -11.1% |
| 2011 | 49.0% | -12.5% |
| 2012 | 42.0% | -14.3% |
| 2013 | 43.0% | +2.4% |
| 2014 | 43.0% | +0.0% |
| 2015 | 42.0% | -2.3% |
| 2016 | 53.0% | +26.2% |
| 2017 | 55.0% | +3.8% |
| 2018 | 61.0% | +10.9% |
| 2019 | 66.0% | +8.2% |
| 2020 | 62.0% | -6.1% |
| 2021 | 50.0% | -19.4% |
| 2022 | 55.0% | +10.0% |
| 2023 | 63.0% | +14.5% |
| 2024 | 63.0% | +0.0% |
| 2025 | 62.0% | -1.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 37.7% | 25.0% | 63.0% | 10 |
| 2010s | 51.0% | 42.0% | 66.0% | 10 |
| 2020s | 59.2% | 50.0% | 63.0% | 6 |
Countries ranked near Nigeria
- 180 Madagascar 64.0% compare
- 181 Gabon 62.0% compare
- 183 Afghanistan 61.0% compare
- 184 Syrian Arab Republic 60.0% compare
More health data for Nigeria
- Un projection of annual infant deaths, annual growth rate -1.08 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8137 % change on previous year (2090)
- Heat deaths vs projected death rates 1,301 (2090)
- Un projection of annual infant deaths 257,921 (2100)
- Population ages 0-14, female, annual growth rate 0.842 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1997 units per person (2025)
- Population ages 0-14, male, annual growth rate 0.8652 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.2055 units per person (2025)
Frequently asked questions
- What is diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Nigeria?
- Diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Nigeria was 62.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest diphtheria tetanus toxoid and pertussis third-dose (dtp3) recorded in Nigeria?
- The highest recorded value was 66.0% in 2019.
- What is the lowest diphtheria tetanus toxoid and pertussis third-dose (dtp3) recorded in Nigeria?
- The lowest recorded value was 25.0% in 2002.
- How does Nigeria rank for diphtheria tetanus toxoid and pertussis third-dose (dtp3)?
- Nigeria ranks 181st out of 194 countries with data for 2025.
- Is diphtheria tetanus toxoid and pertussis third-dose (dtp3) rising or falling in Nigeria?
- Over the last ten years it is up 47.6%. The long-run trend across the full record is rising.
- Where does this Nigeria data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).